Clinical Trials Browser

Phase 2/3 × endostar protein × Thoracic × Clear all

NCT02350361 2015-01-29

Endostar Combination With Chemotherapy and EGFR-TKI in Lung Cancer Rechallenging Treatment After Acquired Resistance.

Phase 2/3 Unknown

Lung Neoplasms